Marcus L. Quek

Marcus L. Quek

Auto-generated profile, based on publicly available information

Marcus L. Quek

Department of Urology, Loyola University Medical Center, Maywood, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Journal of Urology
Verified
Journal Article
Closed access
MQMarcus L. Quek
Marcus L. Quek
JSJohn P. Stein
John P. Stein
SDSiamak Daneshmand
Siamak Daneshmand
GMGus Miranda
Gus Miranda
DTDuraiyah Thangathurai
Duraiyah Thangathurai
DSDonald G. Skinner
Donald G. Skinner
Operative mortality from radical cystectomy has decreased as a result of improvements in surgical and anesthetic care. We reviewed the perioperative deaths from a large group of patients treated with radical cystectomy for primary bladder cancer. All perioperative mortalities from radical cystectomy were identified from a single high volume institution. The medical records were reviewed to assess the cause of death as well as possible contributing factors. From August 1971 to December 2001, 1,359 patients with primary bladder cancer were treated with radical cystectomy and pelvic iliac lymphadenectomy at our institution. Of these patients, 27 (2%) died within 30 days of surgery or before discharge from hospital. Median patient age at surgery was 67 years (range 47 to 78) and males accounted for 81% of the patients. The median time to death was 28 days from cystectomy (range 0 to 80). Most deaths were cardiovascular related (including acute myocardial infarction, cerebrovascular accident, arterial thrombosis) or due to septic complications with resulting multi-organ system failure, followed by pulmonary embolism, hepatic failure and hemorrhage. Septic related mortality was most often associated with postoperative urine or bowel leak. While most deaths occurred before hospital discharge, 2 patients died at home due to a late pulmonary embolus. No association was seen between pathological stage or type of urinary diversion and mortality. Perioperative mortality from radical cystectomy is low in this group of patients. Most deaths are due to cardiovascular or septic complications. Careful patient selection and meticulous surgical technique may help decrease the incidence of perioperative mortality.

1 July 2005 in Journal of Urology
Verified
Journal Article
Closed access
PDF file
MQMarcus L. Quek
Marcus L. Quek
PNPeter W. Nichols
Peter W. Nichols
JYJonathan Yamzon
Jonathan Yamzon
SDSiamak Daneshmand
Siamak Daneshmand
GMGus Miranda
Gus Miranda
DSDonald G. Skinner
Donald G. Skinner
Primary neuroendocrine tumors of the bladder are rare and they include small and large cell variants. We reviewed our experience with treating these tumors with radical cystectomy to evaluate their histopathological characteristics and clinical outcomes. From August 1971 to June 2004, 2,005 patients underwent radical cystectomy for primary bladder cancer at our institution, of whom 25 (1.2%) had neuroendocrine tumors of the bladder, including small cell carcinoma in 20 and large cell carcinoma in 5. Pure neuroendocrine-type histology was identified in 16 cases, including 1 with small and large cell features, while the remaining 9 had mixed histology, that is transitional cell carcinoma in 8 and adenocarcinoma in 1. Multi-agent chemotherapy was administered to 14 patients. Median patient age was 68 years (range 40 to 82) and 19 patients were male (76%). A total of 19 patients (76%) had lymph node involvement, of whom 2 had small liver metastases found intraoperatively, while only 4 (16%) had organ confined tumors and 2 (8%) had extravesical, node negative disease. These tumors tended to have a flat, ulcerative gross appearance with lymphovascular invasion, carcinoma in situ and necrosis present microscopically. Median followup was 11.8 years (range 18 days to 15.1 years). Five-year overall and recurrence-free survival was 10% and 13%, respectively. There was no significant survival difference between small and large cell carcinoma. Mixed histologies tended to do better than pure neuroendocrine tumors, although this did not attain statistical significance (p = 0.064). Patients receiving multimodality therapy had significantly better overall (p = 0.051) and recurrence-free (p = 0.003) survival than those treated with cystectomy alone. Neuroendocrine tumors of the bladder usually present with advanced pathological stage and portend a poor prognosis. Adjuvant chemotherapy protocols may provide improved survival compared with cystectomy alone.

20 May 2003 in Cancer
Verified
Journal Article
Open access
PDF file
SDSiamak Daneshmand
Siamak Daneshmand
MQMarcus L. Quek
Marcus L. Quek
JHJeffry L. Huffman
Jeffry L. Huffman
BACKGROUND: The efficacy and long‐term results of endoscopic management of upper tract transitional cell carcinoma (TCC) were examined. The authors evaluated the accuracy of endoscopic biopsy in determining tumor grade in the subset of patients who underwent open surgical excision.METHODS: Between 1987 and 2001, 50 patients (17 with a solitary kidney) underwent ureteroscopy and biopsy of upper tract TCC. Eleven patients underwent ureterectomy or nephroureterectomy shortly after endoscopic biopsy. There was no follow‐up for nine patients. Thirty patients underwent endoscopic ablation of their primary tumor with laser or electrofulguration at the time of the initial biopsy and were followed with close endoscopic surveillance at 3–4‐month intervals.RESULTS: For the 30 patients who underwent endoscopic ablation, mean follow‐up was 38 months (range, 4–106 months). There was an average of 3.4 recurrences, with an average time to first recurrence of 7 months. Ten of the 30 patients underwent open resection during follow‐up. Six patients exhibited tumor progression at follow‐up. During the follow‐up period, one patient died of recurrent disease, and six died of other causes. Endoscopic biopsy accurately predicted the tumor grade for 8 of the 9 patients who had open tumor resection within 2 months of their last biopsy and for 10 of the 11 patients who had open resection shortly after their initial endoscopic biopsy (overall accuracy, 18 of 20 [90%]).CONCLUSIONS: Endoscopic treatment of focal low‐grade TCC of the upper urinary tract is feasible and safe, provided that vigilant follow‐up and endoscopic surveillance are performed. Endoscopic biopsy provides accurate information regarding tumor grade. Cancer 2003;98:55–60. © 2003 American Cancer Society.DOI 10.1002/cncr.11446

1 August 2004 in Journal of Urology
Verified
Journal Article
Closed access
JSJohn P. Stein
John P. Stein
MDMatthew D. Dunn
Matthew D. Dunn
MQMarcus L. Quek
Marcus L. Quek
GMGus Miranda
Gus Miranda
DSDonald G. Skinner
Donald G. Skinner
Purpose: A serous lined extramural ileal flap valve technique called the T limb was developed to prevent reflux of urine in an orthotopic bladder substitute called the T pouch. We evaluate ...

1 July 2005 in Journal of Urology
Verified
Journal Article
Closed access
PDF file
MQMarcus L. Quek
Marcus L. Quek
JSJohn P. Stein
John P. Stein
PNPeter W. Nichols
Peter W. Nichols
JCJie Cai
Jie Cai
GMGus Miranda
Gus Miranda
DSDonald G. Skinner
Donald G. Skinner
We determined the prognostic significance of lymphovascular invasion (LVI) in patients treated for invasive transitional cell carcinoma of the bladder with radical cystectomy. From August 1971 to June 2004, 2,005 patients underwent radical cystectomy for primary bladder cancer with intent to cure. All patients with nontransitional cell carcinoma histology, palliative procedures, unknown lymphovascular status, less than pT1 pathological stage, or any neoadjuvant or adjuvant chemotherapy/radiation therapy were excluded, leaving 702 comprising the study cohort. Of the 702 patients 249 (36%) had LVI. Median followup was 11.0 years (range 8 days to 23.2 years). Overall 5 and 10-year survival was 51% and 34%, while 5 and 10-year recurrence-free survival was 66% and 64%, respectively. Ten-year recurrence-free survival in patients without LVI was 74% compared with 42% in those with LVI (p <0.0001). Similarly 10-year overall survival was 43% in patients without LVI compared with 18% in those with LVI (p <0.0001). In the organ confined/lymph node negative and lymph node positive pathological subgroups survival outcomes were significantly worse if LVI was present. Although a trend was observed, LVI status was not statistically significant in patients with extravesical node negative disease. Stepwise Cox regression analysis revealed that pathological subgroup (organ confined, extravesical and lymph node positive) (p <0.0001) and LVI status (p = 0.0004) were independent prognostic variables for recurrence-free and overall survival. Lymphovascular invasion appears to be an important and independent prognostic variable in patients with invasive bladder cancer treated with radical cystectomy. LVI status should be determined in cystectomy specimens, which may provide further risk stratification in patients following radical cystectomy.

1 January 2003 in Journal of Urology
Verified
Journal Article
Closed access
MQMarcus L. Quek
Marcus L. Quek
DGDavid A. Ginsberg
David A. Ginsberg